SCHEMBL4753138

SCHEMBL4753138

Brc1ccc(CN2CCN(Cc3ccc4c(c3)OCO4)CC2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.66
KMT2A Q03164 2/20 0.66
MCHR1 Q99705 1/20 0.63
CYP2D6 P10635 2/20 0.61
ALDH1A1 P00352 2/20 0.61
KDM4E B2RXH2 2/20 0.60
USP2 O75604 1/20 0.60
CYP1A2 P05177 1/20 0.60
CYP3A4 P08684 1/20 0.60
HTR1A P08908 1/20 0.60
ADRA2A P08913 1/20 0.60
DRD2 P14416 1/20 0.60
ADRA2B P18089 1/20 0.60
ADRA2C P18825 1/20 0.60
NFKB1 P19838 1/20 0.60
SLC6A2 P23975 1/20 0.60
MAPK1 P28482 1/20 0.60
SLC6A4 P31645 1/20 0.60
CYP2C19 P33261 1/20 0.60
ADRA1A P35348 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL108678 0.90 KDM4E (0.70) MEN1KMT2ACYP2D6KDM4EUSP2
SCHEMBL2316901 0.86 CYP2D6 (0.82) MEN1KMT2ACYP2D6ALDH1A1KDM4E
SCHEMBL19300185 0.86 CYP2D6 (0.63) MEN1KMT2ACYP2D6KDM4EUSP2
SCHEMBL8170046 0.83 KDM4E (0.62) MEN1KMT2ACYP2D6ALDH1A1KDM4E
SCHEMBL19300219 0.83 KDM4E (0.62) MEN1KMT2ACYP2D6ALDH1A1KDM4E
SCHEMBL2056152 0.83 KDM4E (0.62) MEN1KMT2ACYP2D6ALDH1A1KDM4E
SCHEMBL8286300 0.83 KDM4E (0.62) MEN1KMT2ACYP2D6KDM4EUSP2
SCHEMBL22005473 0.83 KDM4E (0.62) MEN1KMT2ACYP2D6ALDH1A1KDM4E
SCHEMBL13062752 0.83 ALDH1A1 (0.64) MEN1KMT2ACYP2D6ALDH1A1KDM4E
SCHEMBL6482711 0.82 MEN1 (0.61) MEN1KMT2ACYP2D6ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008147864-A2 METHODS OF USING PIPERAZINE COMPOUNDS IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-12-04 WO claimed
WO-2008147864-A2 METHODS OF USING PIPERAZINE COMPOUNDS IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-12-04 WO disclosed